Data Extraction (LDH)

High LDH vs
Low/Normal
Adjusted OR
Overall Age LDH Length of
Authors Study Complete LDH Cut- Unadjusted (95% CI) Adjusted
No Country Subjects (Mean±SD)/ (Hypertensiv Observati NOS
(Year) Design Assessment Off Value OR (95% CI) (Low vs Variables
Median e on
Outcome High)
Retinopathy)
(n)
1 Anupama India Retrospe 200 <20 years : Pre Group 3 Pre Birth weight 3 months
et al ctive 18.75% Eclampsia & eclampsia:
(100 VS <2.5 kg
cohort Eclampsia Group 3 VS
was
Group 1: Group 1 Group 3 VS
studied,
21-25 years : Group 1
100 was >800 vs
control) 62.5% <600
>800 vs
<600 45/57 vs
26-30 years: (19/57 vs 55/107
5/107)
15.625%

Birth weight
>30 years: >2.5 kg:
Eclampsia:
3.125% 12/57 vs
38/57 vs
2/107 52/107

Healthy
baby:
18/57 vs
Normal 89/107
0/57 vs
100/107
Sick Baby
21/57 vs
11/107

SVD/IUD
18/57 vs
7/107

Abruptio :
8/57 vs
1/107

DIC :
36/57 vs
0/107

ARF:
5/57 vs
0/107
 MODS :
4/57 vs
0/107

CVA:
9/57 vs
0/107

Retinopathy:
4/57 vs
0/107

Shock
5/57 vs
0/107

Died
11/57 vs
0/107
2 Jaiswar et India Prospecti 146 (39 21–30 years Mild >800 IU/l >800 vs Alive and 1 years
al ve patient preeclampsia, vs <600 <600 IU/l Well
was Severe IU/l
(2011) cohort 36 vs 58 14/11 vs
control, preeclampsia,
47/43
and 107 Eclampsia
cases)
Neonatal
complication
s:
17/11 vs
11/43

Neonatal
deaths:
4/11
vs
5/43

Still births:
13/11 vs
4/43

Perinatal
deaths:
17/11 vs
9/43
3 Qublan Jordan Prospecti 171 Severe PE: Severe PE >800 IU/l >800 IU/l vs Eclampsia: 1 years
ve cohort vs <600 <600 IU/l
et al 28.5±3.3 >800 vs
IU/l
13 vs 28 <600 IU/l
(2005)
4/13 vs 0/28
Mild PE:
30.3±4.9
Abruptio
Placenta:
Normal
2/13 vs 0/28
controls:
30.1±5.7 3
Intracranial
haemmorag
he:
1/13 vs 0/28

HELLP
syndrome:
2/13 vs 0/28

Acute Renal
Failure :
1/13 vs 0/28

Pulmonary
edema:
 1/13 vs 0/28

DIC:
1/13 vs 0/28

Perinatal
Death:
8/13 vs 4/28

Birth
weight(g):
1821±656
/13 vs
1891±498/2
8

4. Kharb et al India Prospecti 200 Preeclampsia >800 IU/l >800 IU/l vs Eclampsia:
(2019) ve vs <600 <600 IU/l
6/20 vs 0/53
cohort IU/l
20 vs 53
study Abruption :
6/20 vs 5/53
HELLP:
4/20 vs 0/53

DIC:
2/20 vs 0/53

Transfer to
RICU/ICU:
3/20 vs 0/53

Preterm
labor:
8/20 vs
10/53

IUGR:
4/20 vs 3/53

Renal
Failure:
2/20 vs 0/53

Maternal
 mortality :
1/20 vs 0/53

5 Kumar A India prospecti 404 Gestational hypertensive >800 IU/l >800 IU/l vs HELLP 1 years
et al ve case hypertension disorders of vs <600 <600 IU/l syndrome:
control : 27.23±2.64 pregnancy IU/l
(2020) 15 vs 371 3/15 vs
study Mild PE:
divided into: 1/371
27.31±2.64
Gestational
Abruption:
hypertension,
Mild 3/15 vs
Severe PE:
preeclampsia 0/371
27.08±2.62 , Severe
preeclampsia,
Eclampsia. Thrombocyt
Eclampsia: openia:
24.08±2.16 0/15 vs
years 0/371

Pulmonary
oedema:
3/15 vs
0/371
Renal
failure:
1/15 vs
0/371

Atonic PPH:
2/15 vs
1/371

Postpartum
LSCS
hysterectom
y:
0/15 vs
1/371

Maternal
mortality :
1/15 vs
0/371

Still birth:
9/15 vs
13/371
 Neonatal
death:
3/15 vs
2/371

6. Pandey et India Retrospe 46 18- 27 years non severe >800 IU/l >800 IU/l vs Alive & well
al ctive gestational vs <600 <600 IU/l
0/3 vs 19/22
cohort hypertension IU/l
(2016) NGSH=
study (NSGH),
severe 0 vs 20
gestational Neonatal
hypertension complication
(SGH), s:
SGH
Eclampsia 0/3 vs 3/22
0 vs 2

Neonatal
Eclampsia:
death :
3 vs 0
0/3 vs 0/22

Still Birth:
2/3 vs 0/22

Perinatal
deaths:
1/3 vs 0/22